CD4 and COVID-19: Taken together, immunosuppressed RTx patients are able to generate SARS-CoV-2 cross reactive T cells, which are comparable to those of healthy blood donors but with a clearly lower frequency of CD4+ T cells reactive to M and N proteins compared to COVID-19 patients.